Navigation Links
Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock
Date:10/12/2010

tp://www.leaddiscovery.co.uk/reports/257/The_World_Asthma_and_COPD_Treatment_Market_20062011_A_Changing_Market_with_Increasing_Potential">www.leaddiscovery.co.uk/reports/257/The_World_Asthma_and_COPD_Treatment_Market_20062011_A_Changing_Market_with_Increasing_Potential

Chief Financial Officer Richard Cowan stated, "These much needed treatments for very serious health problems, such as cancer, AIDS, chronic pain, PTSD and many others, offer us the opportunity to grow this company into the major cannabis pharmaceutical firm it should be. The Cannabis Science business model – as a bridge between the medical marijuana world and pharmaceutical development -- is unique, and places it in an excellent position to rise above the absurd stigmas and serious questions about medical cannabis. We will do this by leading the development of FDA approved cannabis-based pharmaceuticals, which will available through pharmacies nationwide. Several of these drugs have potential 'block-buster' status, a multibillion market. In the meantime, the significant revenue streams possible through intrastate over-the-counter dispensary markets provide us with multiple opportunities for growth."

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement co
'/>"/>

SOURCE Cannabis Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill
2. DC Patients Cooperative Urges Changes to the Proposed Medical Cannabis Marijuana Regulations
3. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global A Dialyzer ... 2014" report to their offering. ... Reprocessor ) Industry Report 2014 is a professional ... the A dialyzer reprocessing machine industry. The ...
(Date:6/1/2015)... N.Y. , June 1, 2015 ... HRTX ) today announced positive, top-line results ... MAGIC evaluated the efficacy and safety of the ... SUSTOL ® (granisetron injection, extended release) as ... (IV) neurokinin-1 (NK 1 ) receptor antagonist fosaprepitant ...
(Date:6/1/2015)... CLEVELAND , June 1, 2015 Researchers ... and Case Western Reserve University School of Medicine will ... evaluating a potential novel combination treatment for cancer patients ... gene mutations in small cell lung cancer (SCLC), at ... (ASCO) Annual Meeting in Chicago . ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3New cancer therapy study results - MAGIC Trial 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3
... New results from an observational substudy from ... Association (AHA) Scientific Sessions annual meeting showed that ... artery bypass graft surgery (CABG) had a reduced ... Plavix® (clopidogrel) (2.3 percent versus 8.7 percent respectively, ...
... one of the world,s leading research and advisory firms ... the launch of several novel agents, the hepatitis C ... approximately $2 billion in 2009 to nearly $7.5 billion ... Spain, the United Kingdom and Japan. Thereafter, the market ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 2The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 3
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... New York, NY (PRWEB) June 02, 2015 ... leader in minimally invasive spine surgery with three locations ... office in New York City. The new facility is ... York, N.Y. 10028. Telephone consultations and appointments can be ... founder and chief surgeon at Atlantic Spine Center, has ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Pacifica ... fund set up by current and former students to ... beloved faculty member from 2002 until his death in ... intelligence, and depth of feeling, as well as his ... His capacities as an analyst, teacher, and writer were ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in business. NAPW is the nation’s leading networking ... members and over 200 operating Local Chapters. , “I’m ... NAPW President Star Jones. “Job satisfaction is essential for ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into the NAPW VIP ... with this prestigious distinction for leadership in academics. With ... Chapters, NAPW is the nation’s leading networking organization exclusively ... with this important distinction,” said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... , INDIANAPOLIS, Sept. 9 WellPoint, Inc. (NYSE: ... Medicare Advantage and 2010 Medicare Part D health benefit plans effective Oct. ... Medicare Part D health benefit plans on Nov. 15, 2009 for the ... Medicare and Medicaid Services (CMS) has determined that WellPoint has corrected deficiencies ...
... approval of second HPV vaccine, Cervarix, to prevent cervical cancer ... recommended Wednesday that use of the vaccine Gardasil, already administered ... help prevent genital warts in young males. , A U.S. ... expanded use of the vaccine for males 9 to 26. ...
... , WASHINGTON, Sept. 9 San Francisco Mayor ... tonight for the President,s historic speech on healthcare reform before a ... As Co-Chair of the U.S. Conference of Mayors Healthcare ... mayors around the country to urge Congress to pass comprehensive health ...
... dormant, common virus that crosses over into brain , WEDNESDAY, ... of the reason why Tysabri, a drug used to treat ... but potentially deadly brain disease in some patients. , The ... its slumber, allowing it to cross into the brain. , ...
... Sept. 9 Stryker Corporation (NYSE: SYK ) announced ... 20, 2009, at 4:30 p.m., Eastern Time, to discuss the Company,s ... an operational update. Operating results for the quarter ended September 30, ... , To participate in the conference call dial 800-706-7745 ...
... , PITTSBURGH, Sept. 9 The California ... host filmmaker Michael Moore at a special reception Monday night, along ... A Love Story" at the AFL-CIO national convention in Pittsburgh. , ... will outline the ongoing campaign for single payer healthcare reform by ...
Cached Medicine News:Health News:Statement on WellPoint's Re-Entry into Medicare Market 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 2Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 3Health News:FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 4Health News:Mayor Gavin Newsom to Be President Obama's Guest for Healthcare Reform Speech to the Nation 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:Stryker To Host Conference Call on October 20, 2009 2Health News:Nurses, AFL-CIO Unions to Host Michael Moore and Special Screening of New Film at AFL-CIO Convention 2
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: